BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $210,798 | $148,061 | $134,796 | $207,572 |
| - Cash | $215,573 | $220,330 | $257,486 | $354,349 |
| + Debt | $7,133 | $8,746 | $10,312 | $8,704 |
| Enterprise Value | $2,358 | -$63,523 | -$112,378 | -$138,073 |
| Revenue | $2,054 | $2,412 | $1,451 | $0 |
| % Growth | -14.8% | 66.2% | – | – |
| Gross Profit | $2,054 | $2,412 | $1,451 | $0 |
| % Margin | 100% | 100% | 100% | – |
| EBITDA | -$19,973 | -$21,304 | -$12,636 | -$20,763 |
| % Margin | -972.4% | -883.3% | -870.8% | – |
| Net Income | -$20,171 | -$21,563 | -$12,928 | -$21,129 |
| % Margin | -982% | -894% | -891% | – |
| EPS Diluted | -0.56 | -0.6 | -0.36 | -1.97 |
| % Growth | 6.7% | -66.7% | 81.7% | – |
| Operating Cash Flow | -$16,044 | -$19,969 | -$17,363 | -$5,138 |
| Capital Expenditures | -$22 | -$159 | -$426 | -$26 |
| Free Cash Flow | -$16,066 | -$20,128 | -$17,789 | -$5,164 |